coronavirus to participate in a new Covid treatment trial. NHS Greater Glasgow and Clyde is working alongside University of Glasgow experts to research the impact that an antiviral tablet can have on symptoms.
The drug, which is called Favipiravir, is targeted at those in the early stages of the virus and must be taken within four days of a positive Covid test result.
The treatment is intended for those who have milder symptoms of the virus rather than those who are in need of hospital treatment.
Researchers will assess the effectiveness of the drug and the potential that it has in reducing the time it takes to recover from coronavirus.
Read more on dailyrecord.co.uk